. 2017 Dec 8;17:178. doi: 10.1186/s12890-017-0504-5

Table 6.

Pre-specified indicators of guideline-concordant investigation

	RIC (%)	Non-RIC (%)	p-value^a
PET scans in stage I/II NSCLC	48/51 (94)	45/ 55(82)	0.05^a
Brain imaging in stage IIIA NSCLC	26/ 51(51)	14/ 37(38)	0.22^a
Brain imaging in SCLC	24/26 (92)	5/7 (72)	0.13^b
Patient seen in multi-disciplinary lung cancer clinic, or case reviewed at Tumor Board	144/ 195 (74)	73/132 (55)	<0.01^a

Chi-squared^a or Fisher’s exact test^b were used